Bioventus Inc. provided earnings guidance for the year 2024. For the year, the company expects net sales to be in the range of $520 million to $535 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.48 USD | +0.15% | -3.28% | +22.96% |
May. 07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
May. 07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.96% | 413M | |
-25.77% | 7.29B | |
+6.34% | 6.75B | |
+18.57% | 5.5B | |
-18.64% | 4.75B | |
+18.17% | 4.1B | |
-20.73% | 3.93B | |
-27.83% | 2.7B | |
+43.60% | 2.31B | |
+1.86% | 2.06B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Bioventus Inc. Provides Earnings Guidance for the Year 2024